| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9499bfaa0f7c82a0a4bc86f34406d477
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae77141363047644b62aa09764948bb5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2017-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3963ce85d3e7e20acb9a64b3e9bf4b7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_542b7f4f88632b25b3645c1911bd09c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a7c065fb665fa580dec66654400d684
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8af6cb56039da72c040f10c30bc57802 |
| publicationDate |
2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017207702-A1 |
| titleOfInvention |
Androgen receptor splice variants and androgen deprivation therapy |
| abstract |
The present invention provides androgen receptor splice variants that are associated with resistance to androgen deprivation therapy, such as treatment with abiraterone acetate or enzalutamide. The present invention is especially useful in the field of oncology, including prostate cancer diagnosis, characterization, classification and treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3755814-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3620538-A1 |
| priorityDate |
2016-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |